Radiotherapy for thyroid-associated orbitopathy

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue SUPPL. 5, 1999, Pages

  Kahaly, George J ^a   Roesler, H P ^a   Kutzner, J ^a   Pitz, S ^a   Muller Forell W ^a   Beyer, J ^a   Mann, W ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Retrobulbar irradiation; Thyroid associated orbitopathy

Indexed keywords

GLUCOCORTICOID; PREDNISONE;

CONFERENCE PAPER; CONJUNCTIVITIS; GAMMA RADIATION; HUMAN; IONIZING RADIATION; MOLECULAR BIOLOGY; ORBIT DISEASE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; RETINOPATHY; RETROBULBAR OPTIC NEUROPATHY; RISK ASSESSMENT; SAFETY; SMOKING; THYROID DISEASE; VISUAL IMPAIRMENT; X IRRADIATION;

EID: 0032707419     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212186     Document Type: Conference Paper

References (56)

1. Bartalena L, Marcocci C, Tanda ML, et al. Cigarette smoking and Graves' ophthalmopathy. Ann Intern Med 1998; 129: 632-5
2. Beierwaltes WH. X-ray treatment of malignant exophthalmos: a report of 28 patients. J Clin Endocrinol 1953; 13: 1090-1100
3. Blank LECM, Barendsen GW, Prummel MF, Stalpers L, Wiersinga W, Koornneef L. Probable risk of tumor induction after retroorbital irradiation for Graves' ophthalmopathy. Radiother Oncol 1996; 40: 187-8
4. Canney PA, Dean St. Transforming growth factor beta. A promoter of late connective tissue injury following radiotherapy? Br J Radiol 1990; 63: 620-3
5. DeGroot LJ, Gorman CA, Pinchera A, et al. Radiation and Graves' ophthalmopathy. Therapeutic controversies. J Clin Endocrinol Metab 1995; 80: 339-49
6. Elsas T, Thorud E, Jetne V, Conradi IS. Retinopathy after low dose irradiation for an intracranial tumor of the frontal lobe. Acta Ophthalmol 1988; 66: 65-8
7. Erickson BA, Harris GJ, Lewandowski MF, Murray KJ, Massaro BM. Echographic monitoring of response of extraocular muscles to irradiation in Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 1995: 31: 651-60
8. Förster G, Kahaly G. Endokrine Orbitopathie. Med Klin 1998; 93: 365-373
9. Förster G, Otto E, Hansen C, Ochs K, Kahaly GJ. Analysis of orbital T cells in Thyroid-Associated Opthalmopathy. Clin Exp Immunol 1998; 112: 427-34
10. Gorman CA. Orbital radiotherapy for Graves'opthalmopathy: a randomized, double blind, prospective, clinical trial. International Symposium on Graves'ophthalmopathy, Amsterdam, NL, Nov. 27-28, 1998
11. Haimovitzfriedemann A, Vlodavsky I, Chaudhuri A, Witte L, Fuks Z. Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res 1991; 51: 2552-8
12. Hansen C, Otto E, Kuhlemann K, Förster G, Kahaly GJ. Glycosaminoglycans in autoimmunity. Clin Exp Rheumatol 1996; 14: 59-68
13. Hansen C, Fraiture B, Rouhi R, Otto E, Förster G, Kahaly G. HPLC glycosaminoglycan analysis in patients with Graves'disease. Clin Science 1997; 92: 511-7
14. Hansen C, Rouhi R, Förster G, Kahaly GJ. Increased Sulfatation of Orbital Glycosaminoglycans in Graves'Ophthalmopathy. J Clin Endocrinol Metab 1999; 84: 1409-1413
15. Hendry JH. Biological response modifiers and normal tissue injury after irradiation. Radiat Oncol 1994; 4: 123-32
16. Hildebrandt G, Seed MP, Freemantle CN, Alam CAS, Colville-Nash PR, Trott KR. Mechanisms of the anti-inflammatory activity of low-dose radiation therapy. Int J Radial Biol 1998; 74: 367-78
17. Hofbauer LC, Mühlberg T, Konig A, Heufelder G, Schworn HD, Heufelder AE. Soluble Inlerleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy. J Clin Endocrinol Metab 1997; 82: 2244-7
18. Jones A. Orbital x-ray therapy of progressive exophthalmos. Br J Radiol 1951; 24: 637-46
19. Juler FA. Acute purulent keratitis in exophthalmic goiter treated by repeated tarsorrhaphy resection of cervical sympathetis and x-rays: retention of vision in one eye. Trans Ophthalmol Soc UK 1913; 33: 58-62
20. Kahaly GJ, Hansen C, Felke B, Dienes HP. Immunohistochemical staining of retrobulbar adipose tissue in Graves'ophthalmopathy. Clin Immunol Immunopathol 1994; 73: 53-62
21. Kahaly GJ, Diaz M, Hahn K, Beyer J, Bockisch A. Indium-111-pentetreotide scintigraphy in Graves'ophthalmopathy. J Nucl Med 1995; 36: 550-554
22. Kahaly GJ, Görges R, Diaz M, Hommel G, Bockisch A. Indium-111-pentetreotide in Graves'disease. J Nucl Med 1998; 39: 533-536
23. Kahaly GJ, Roesler HP, Pitz S, Hommel G. Low vs high dose radiotherapy for Graves'ophthalmopathy. J Clin Endocrinol Metab 1999 (in press)
24. Kao SCS, Kendler DL, Nugent RA, Adler JS, Rootman J. Radiotherapy in the management of thyroid orbitopathy. Arch Ophthalmol 1993; 111: 819-23
25. Kinyoun JL, Kalina RE, Brower SA, Mills RP, Johnson RH. Radiation retinopathy after orbital irradiation for Graves'ophthalmopathy. Arch Ophthalmol 1984; 102: 1473-6
26. Kriss JP, Petersen IA, Donaldson SS, McDougall IR. Supervoltage orbital radiotherapy for progressive Graves'opthalmopathy: results of a twenty year experience. Acta Endocrinol 1989; 121: 154-9
27. Langberg CW, Hauer-Jensen M, Sung SS, Kane C. Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Radiother Oncol 1994; 32: 29-36
28. Leer JWH, van Houtte P, Davelaar J. Indications and treatment schedules for irradiation of benign diseases: a survey. Radiother Oncol 1998; 48: 249-57
29. Lopez PF, Sternberg P, Dabbs CK, Volgler WR, Crocker I, Kalin NS. Bone marrow transplant retinopathy. Am J Ophthalmol 1991; 112:635-46
30. Mandeville FB. Roetgen therapy of orbital-pituitary portals for progressive exophthalmos following subtotal thyroidectomy. Radiology 1943; 41: 268-71
31. Marcocci C, Bartalena L, Bruno-Bossio G, et al. Orbital radiotherapy in the treatment of endocrine ophthalmopathy: Why and when? In: Kahaly G (ed) Endocrine Ophthalmopathy - Molecular, immunological and clinical aspects. Karger, Basel, 1993, pp131-41
32. Martin M, Lefaix JL, Pinton P, Crechet F, Daburon F. Temporal modulation of TGF-β1 and β-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat Res 1993; 134: 63-70
33. McCartney-Francis N, Allen JB, Mizel DE, et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993; 178: 749-54
34. Miller ML, Goldberg SH, Bullock JD. Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy. Am J Ophthalmol 1991; 112: 600-1
35. Mourits MP. Randomized double blind trial of orbital radiotherapy vs sham irradiation in Graves'ophthalmopathy. International Symposium on Graves'ophthalmopathy, Nov. 27-28, 1998
36. Mühlberg T, Spitzweg C, Heberling HJ, Heufelder AE. Regulation of Interleukin-1 receptor antagonist gene and protein variants by radiotherapy in Graves' retroocular fibroblasts. J Endocrinol Invest 1998; 21 (Suppl 4): 67
37. Nakahara H, Noguchi S, Murakami N, et al. Graves'ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids. Radiology 1995; 196: 857-62
38. Nikoskelainen E, Joensuu H. Retinopathy after irradiation for Graves'ophthalmopathy. Lancet 1989; 2: 690
39. Nygaard B, Specht L. Transitory blindness after retrobulbar irradiation of Graves'ophthalmopathy. Lancet 1998; 351: 725-6
40. Olivotto IA, Ludgate CM, Allen LH, Rootman J. Supervoltage radiotherapy for Graves'ophthalmopathy. CCABC technique and results. Int J Radiation Oncol Biol Phys 1985; 11: 2085-90
41. Otto E, Ochs K, Hansen C, Wall J, Kahaly G. Orbital tissue-derived T lymphocytes from patients with Graves'ophthalmopathy recognize autologous orbital antigens. J Clin Endocrinol Metab 1996; 81: 3045-50
42. Parker RG, Withers HR. Radiation retinopathy. JAMA 1988; 259: 43
43. Petersen IA, Kriss JP, McDougall IR, Donaldson SS. Prognostic factors in the radiotherapy of Graves'ophthalmopathy. Int J Radiat Oncol Biol Phys 1990; 19: 259-64
44. Prummel MF, Wiersinga WM, Mourits MP, Koorneef L, Berghout A, vd Gaag R. Influence of abnormal thyroid function on the severity of accompanying Graves'ophthalmopathy. Arch Int Med 1990; 150: 1098-1101
45. Prummel MF, Mourits MP, Blank L, Berghout A, Koorneef L, Wiersinga WM. Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet 1993; 342: 949-54
46. Ravin JG, Sisson JC, Knapp WT. Orbital radiation for the ocular changes of Graves'disease. Am J Ophthalmol 1975; 79: 285-8
47. Remy J, Wegrowski J, Crechet F, Martin M, Daburon F. Longterm over-production of collagen in radiation-induced fibrosis. Radiat Res 1991; 125: 14-19
48. Rodemann HP, Peterson HP, Schwenke K, von Wangenheim KH. Terminal differentiation of human fibroblasts is induced by radiation. Scan Microsc 1992; 5: 1135-43
49. Rodemann HP, Bamberg M. Cellular basis of radiation-induced fibrosis. Radiother Oncol 1995; 35: 83-90
50. Sandler HM, Rubenstein JH, Fowble BL, Sergott RC, Savino PJ, Bosley TM. Results of radiotherapy for thyroid ophthalmopathy. Int J Radiat Oncol Biol Phys 1989; 17: 823-7
51. Sautter-Bihl M-L. Orbital radiotherapy: recent experience in Europe. In: Wall JR, How J, eds. Graves'ophthalmopathy. Cambridge: Blackwell 1990: 145-57
52. Snijders-Keilholz A, De Keizer RJ, Goslings BM, Van Dam EWCM, Jansen JThM, Broerse JJ. Probable risk of tumour induction after retroorbital irradiation for Graves'ophthalmopathy. Radiother Oncol 1996; 38: 69-71
53. Tan HS. Orbital radiotherapy in Graves'ophthalmopathy: is it safe?. International Symposium on Graves'ophthalmopathy, Amsterdam, NL, Nov. 27-28, 1998
54. Trott KR. Therapeutic effects of low radiation doses. Strahlenther Onkologie 1994; 170: 1-12
55. Viebahn M, Marricks ME, Osterloh MD. Synergism between diabetic and radiation retinopathy: case report and review. Br J Ophthalmol 1991; 75: 29-32
56. Woloschak GE, Chang-Liu CM. Differential modulation of specific gene expression following high- and low radiations. Radiat Res 1990; 124: 183-7